Post by GSK on X
GSK@GSK
X#News for #Investors and #Media
China’s National Medical Products Administration (NMPA) has approved our therapy to treat an incurable and challenging blood cancer.
For more information, visit: t.co
19 likes2 repliesPosted Apr 20, 2026